| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Strongbridge Biopharma plc | 5,394,994 | 12,948,000 | 44.17% | ||
| 2 | Agile Therapeutics, Inc. | 2,123,567 | 12,104,000 | 41.30% | ||
| 3 | BERKSHIRE HATHAWAY INC DEL | 8,945 | 1,458,000 | 4.97% | ||
| 4 | GARRISON CAP INC | 52,128 | 487,000 | 1.66% | ||
| 5 | CM FIN INC COM | 42,757 | 398,000 | 1.36% | ||
| 6 | ACLARIS THERAPEUTICS INC COM | 13,241 | 359,000 | 1.22% | ||
| 7 | PARATEK PHARMACEUTICALS INC | 21,923 | 338,000 | 1.15% | ||
| 8 | TEAM HEALTH HOLDINGS INCORPORATED | 7,548 | 328,000 | 1.12% | ||
| 9 | ADIENT PLC | 4,737 | 278,000 | 0.95% | ||
| 10 | American Capital Senior Floating Ltd | 17,931 | 213,000 | 0.73% | ||
| 11 | CIDARA THERAPEUTICS INC | 20,358 | 212,000 | 0.72% | ||
| 12 | STELLUS CAP INVT CORP | 15,593 | 188,000 | 0.64% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-17-001665, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
